advertisement

Topcon

Wu JH 24

Showing records 1 to 24 | Display all abstracts from Wu JH

96480 Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
Wu JH
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 937-948
96150 Rates of Circumpapillary Retinal Nerve Fiber Layer Thinning and Capillary Density Loss in Glaucomatous Eyes with Disc Hemorrhage
Nishida T
American Journal of Ophthalmology 2021; 235: 24-31
96079 Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series
Chang HL; Chang HL
Scientific reports 2021; 11: 21443
96311 Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost
Wu JH
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 556-564
96480 Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
Chang SN
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 937-948
96311 Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost
Wang TH
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 556-564
96079 Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series
Kuo BI
Scientific reports 2021; 11: 21443
96150 Rates of Circumpapillary Retinal Nerve Fiber Layer Thinning and Capillary Density Loss in Glaucomatous Eyes with Disc Hemorrhage
Moghimi S
American Journal of Ophthalmology 2021; 235: 24-31
96079 Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series
Kuo BI; Wu JH
Scientific reports 2021; 11: 21443
96480 Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
Nishida T
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 937-948
96150 Rates of Circumpapillary Retinal Nerve Fiber Layer Thinning and Capillary Density Loss in Glaucomatous Eyes with Disc Hemorrhage
David RCC
American Journal of Ophthalmology 2021; 235: 24-31
96311 Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost
Huang JY
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 556-564
96150 Rates of Circumpapillary Retinal Nerve Fiber Layer Thinning and Capillary Density Loss in Glaucomatous Eyes with Disc Hemorrhage
Chang AC
American Journal of Ophthalmology 2021; 235: 24-31
96311 Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost
Su CC
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 556-564
96079 Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series
Huang WL
Scientific reports 2021; 11: 21443
96480 Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
Kuo BI
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 937-948
96150 Rates of Circumpapillary Retinal Nerve Fiber Layer Thinning and Capillary Density Loss in Glaucomatous Eyes with Disc Hemorrhage
Chang AC
American Journal of Ophthalmology 2021; 235: 24-31
96480 Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
Kuo BI
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 937-948
96150 Rates of Circumpapillary Retinal Nerve Fiber Layer Thinning and Capillary Density Loss in Glaucomatous Eyes with Disc Hemorrhage
Wu JH
American Journal of Ophthalmology 2021; 235: 24-31
96480 Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
Lin JW
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 937-948
96079 Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series
Su CC
Scientific reports 2021; 11: 21443
96150 Rates of Circumpapillary Retinal Nerve Fiber Layer Thinning and Capillary Density Loss in Glaucomatous Eyes with Disc Hemorrhage
El-Nimri N
American Journal of Ophthalmology 2021; 235: 24-31
96079 Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series
Chen WL
Scientific reports 2021; 11: 21443
96150 Rates of Circumpapillary Retinal Nerve Fiber Layer Thinning and Capillary Density Loss in Glaucomatous Eyes with Disc Hemorrhage
Proudfoot JA; Kamalipour A; Zangwill LM; Weinreb RN
American Journal of Ophthalmology 2021; 235: 24-31

Issue 22-3

Change Issue


advertisement

Oculus